Upsher-Smith intros generic Zyprexa
Olanzapine tablets had a market value of roughly $46 million for the 12 months ending August 2024, per IQVIA.
Upsher-Smith is offering olanzapine tablets, in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths.
The medication is the generic of Zyprexa.
[Read more: Upsher-Smith, NASPA recognize 47 pharmacists with 2022 NASPA Excellence in Innovation Award]
Olanzapine is an atypical antipsychotic indicated:
As oral formulation for the treatment of schizophrenia; acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder and adjunct to valproate or lithium in the treatment of manic or mixed episodes associated with bipolar I disorder.
[Read more: Upsher-Smith, NASPA recognize 47 pharmacists with 2022 NASPA Excellence in Innovation Award]
Olanzapine tablets had a market value of roughly $46 million for the 12 months ending August 2024, per IQVIA.